MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ

Scientific Reports
Mingrong LüFei Sun

Abstract

Tamoxifen represents a major adjuvant therapy to those patients with estrogen receptor-alpha positive breast cancer. However, tamoxifen resistance occurs quite often, either de novo or acquired during treatment. To investigate the role of miR-320a in the development of resistance to tamoxifen, we established tamoxifen-resistant (TamR) models by continually exposing MCF-7 or T47D breast cancer cells to tamoxifen, and identified microRNA(miRNA)-320a as a down-regulated miRNA in tamoxifen resistant cells. Re-expression of miR-320a was sufficient to sensitize TamR cells to tamoxifen by targeting cAMP-regulated phosphoprotein (ARPP-19) and estrogen-related receptor gamma (ERRγ) as well as their downstream effectors, c-Myc and Cyclin D1. Furthermore, progesterone (P4) promoted the expression of miR-320a by repressing c-Myc expression, while estrogen (E2) exerted the opposite effect. These results suggest the potential therapeutic approach for tamoxifen-resistant breast cancer by restorating miR-320a expression or depleting ARPP-19/ERRγ expression.

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
May 4, 2005·Breast Cancer Research and Treatment·Marie AhnströmOlle Stål
May 18, 2006·Journal of the National Cancer Institute·Caroline HolmGöran Landberg
Oct 19, 2006·Experimental and Molecular Pathology·Maricarmen D Planas-SilvaJ S Smith
Aug 5, 2008·Cancer Research·Troels SchepelerClaus L Andersen
Aug 19, 2008·The Journal of Biological Chemistry·Tyler E MillerSarmila Majumder
Nov 1, 2008·Cancer Research·Rebecca B RigginsRobert Clarke
Apr 14, 2010·International Journal of Molecular Sciences·Hong-Fei XiaXu Ma
Dec 22, 2010·Molecular Cancer·Diana M CittellyFrank E Jones
Feb 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Todd W MillerCarlos L Arteaga
Jun 2, 2011·Results and Problems in Cell Differentiation·Olivier Haccard, Catherine Jessus
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kideok JinSaraswati Sukumar
Dec 20, 2011·Nature Cell Biology·A BroniszM C Ostrowski
May 24, 2012·Neuroreport·Robin E White, Rona G Giffard
Jan 25, 2013·International Journal of Molecular Sciences·Rocío García-BecerraJavier Camacho

❮ Previous
Next ❯

Citations

Jun 22, 2017·Natural Products and Bioprospecting·Rui-Min YangSheng-Xiong Huang
Jul 4, 2018·Journal of Cellular Physiology·Fahimeh Zamani RaraniBahman Rashidi
Jan 19, 2018·The Journal of Obstetrics and Gynaecology Research·Tian GaoQian Wang
Sep 25, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lufeng ZhengTao Xi
Jul 6, 2016·Neuroreport·Tao JiangJinghai Wan
Mar 4, 2020·Current Drug Metabolism·Sadat ShafiAbul Kalam Najmi
Nov 21, 2017·Molecular Medicine Reports·Xiancai GeQin Zhang
May 26, 2020·Cellular and Molecular Life Sciences : CMLS·Lucile Crevet, Jean-Marc Vanacker
Jun 11, 2019·Frontiers in Endocrinology·Aradhana RaniJohn Murphy
May 24, 2016·International Journal of Oncology·Atsushi OkatoNaohiko Seki
Apr 14, 2017·Bone & Joint Research·Y JinJ Zheng
Sep 13, 2018·Molecular Cancer Research : MCR·Yue XueQingqing Wang
Dec 4, 2020·Biomolecules·Perrine Goguet-RubioAnna Castro
Jan 2, 2021·Open Medicine·Hongkai ZhangRong Ma
Apr 4, 2021·Antioxidants·Charlotte Scholtes, Vincent Giguère
Oct 1, 2020·International Journal of Molecular Sciences·Kashmiri LandeRoy Karnati
Jun 3, 2021·Biomedicines·Yuanyuan LiangLiling Tang
Aug 8, 2021·Cancers·Jéssica Fernanda BarazettiJaqueline Carvalho de Oliveira
Sep 16, 2021·Cancer Metastasis Reviews·Iris Garrido-CanoPilar Eroles

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
xenografting

Software Mentioned

miRanda
PicTar
TargetScan
PrismDemo

Related Concepts